Search results for: Multi-Indication Medicines
Filter search results
EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings
27 February 2025
…an intervention spans across multiple value sets (e.g. EQ-5D-Y and EQ-5D). OHE’s David Mott is active in this research area; he is currently contributing to the development of UK EQ-5D-Y-3L…
Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next
10 April 2025
…that people sometimes struggle to interpret broad terms like “cognition” or “cognitive impairment”. Their qualitative work has also highlighted that asking multiple detailed questions could create additional burden for respondents,…
Altering the trajectory of HIV in Europe
22 May 2025
…to progress Significant barriers continue to hinder efforts to eliminate HIV transmission in Europe. This report highlights key barriers, which exist at multiple levels: Individual barriers: Low awareness of risk…
Careers at OHE
…organisational skills with the ability to manage multiple tasks and deadlines; have excellent written and verbal communication skills; be familiar with digital event platforms and/or social media (e.g. LinkedIn, Zoom); …
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
…conceptual framework to capture the full value of AMR diagnostics. It provides a critical step towards appropriate value assessment of AMR diagnostics, raising awareness of the multifaceted benefits of AMR…
Rosanna Tarricone
8 June 2025
…of London, after graduating in Management from Bocconi University. She is Principal Investigator of HEU-EFS, a large, EU-funded, multi-annual research project aimed at developing a European Program for Early Feasibility…
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…it hard to plan for the long-term; we need protected, multi-year investment in prevention, especially immunisation. A lack of compelling data: we’ve struggled to fully quantify and communicate prevention’s broad…
OHE responds to the NHS Ten Year Plan
3 July 2025
…Many of the recommendations in the Ten Year Plan require high upfront costs and sustained financing over multiple funding cycles. The NHS can’t be expected to foot the bill for…
Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
24 September 2025
…pharmaceutical products to support reimbursement decisions across public and private sectors. The HTA process follows a structured, multi-step format aimed at ensuring transparency and alignment with national priorities. It begins…